Omeros Corp. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
14,101.00
6,886.00
28,263.00
45,331.00
83,749.00
60,498
Total Accounts Receivable
379.00
392.00
6,517.00
12,037.00
17,144.00
22,818
Inventories
-
568.00
472.00
1,128.00
443.00
88
Other Current Assets
337.00
1,311.00
1,894.00
1,766.00
7,036.00
6,463
Total Current Assets
14,817.00
9,157.00
37,146.00
60,262.00
108,372.00
89,867
Net Property, Plant & Equipment
939.00
782.00
951.00
1,181.00
2,121.00
3,845
Total Investments and Advances
679.00
679.00
10,679.00
5,835.00
5,835.00
1,154
Other Assets
100.00
472.00
219.00
-
-
1,070
Total Assets
16,535.00
11,090.00
48,995.00
67,278.00
116,328.00
95,936
ST Debt & Current Portion LT Debt
5,600.00
6,446.00
73.00
198.00
490.00
Accounts Payable
2,329.00
4,915.00
6,428.00
2,519.00
6,691.00
Other Current Liabilities
3,944.00
7,070.00
9,752.00
13,354.00
19,126.00
Total Current Liabilities
11,873.00
18,431.00
16,253.00
16,071.00
26,307.00
Long-Term Debt
14,898.00
26,263.00
49,769.00
79,512.00
84,117.00
Other Liabilities
8,148.00
9,050.00
9,207.00
9,142.00
8,718.00
Total Liabilities
34,919.00
53,744.00
75,229.00
104,725.00
119,142.00
Common Equity (Total)
18,384.00
42,654.00
26,234.00
37,447.00
2,814.00
Total Shareholders' Equity
18,384.00
42,654.00
26,234.00
37,447.00
2,814.00
Total Equity
18,384.00
42,654.00
26,234.00
37,447.00
2,814.00
Liabilities & Shareholders' Equity
16,535.00
11,090.00
48,995.00
67,278.00
116,328.00

About Omeros

View Profile
Address
The Omeros Building
Seattle Washington 98119
United States
Employees -
Website http://www.omeros.com
Updated 07/08/2019
Omeros Corp. operates as a biopharmaceutical company specializes in discovery, development, and commercializes of both small-molecule and protein therapeutics for large -market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.